425: K-C, Kenvue Transaction: Proxy Solicitation Update

Kimberly-Clark and Kenvue provide an update on their proposed transaction, including details on proxy solicitation and important investor information.

Summary

• This communication serves as a legal disclosure regarding the proposed transaction between Kimberly-Clark Corporation (K-C) and Kenvue Inc.
• It is not an offer to sell, a solicitation to buy, or a prospectus, but rather solicitation material for the proposed transaction.
• K-C and Kenvue filed a registration statement on Form S-4 on December 4, 2025, which was amended on December 12, 2025, and declared effective by the SEC on December 16, 2025.
• A definitive joint proxy statement/prospectus was filed and mailing commenced on December 16, 2025, to seek stockholder approval for transaction-related proposals.
• Investors and stockholders are urged to carefully read the registration statement and definitive joint proxy statement/prospectus, along with other SEC filings, for important information.
• Information regarding participants in the proxy solicitation, including directors and executive officers of both companies, is referenced in their respective Annual Reports on Form 10-K, proxy statements, and Current Reports on Form 8-K.
• Changes in beneficial ownership of securities by directors and executive officers are reflected in various Form 3, 4, and 5 filings with the SEC.
• Projected financial information for the combined businesses is based on management estimates and assumptions, is for illustrative purposes only, and has not been prepared in conformance with Regulation S-X pro forma requirements.

Sentiment

Score: 5

Explanation: The filing is a neutral, procedural legal disclosure regarding a proposed transaction. It contains extensive cautionary language about forward-looking statements and risks, balancing any implied positives with potential challenges, resulting in a neutral sentiment.

Positives

• The proposed transaction aims to achieve anticipated benefits and synergies, including improved cash flow generation and a favorable post-closing capital structure.
• The transaction is expected to support growth initiatives, innovations, and marketing efforts.

Risks

• The occurrence of any event, change, or circumstance that could lead to the termination of the merger agreement, potentially requiring a party to pay a termination fee.
• Conditions for completing the proposed transaction, including stockholder and regulatory approvals, may not be satisfied in a timely manner or at all.
• The possibility of competing offers or transaction proposals emerging.
• Risks arising from the integration of the K-C and Kenvue businesses.
• Uncertainty regarding rating agency actions following the transaction.
• Anticipated benefits and synergies of the proposed transaction may not be realized when expected or at all.
• The proposed transaction may not be completed in a timely manner or at all.
• Unexpected costs or expenses may result from the proposed transaction.
• Risk of litigation related to the proposed transaction, potentially leading to expense or delay.
• Disruption to ongoing business operations and diversion of management's time due to the proposed transaction.
• The proposed transaction may adversely affect the ability of K-C and Kenvue to retain key personnel, customers, and suppliers.
• The credit ratings of the combined company could decline following the proposed transaction.
• The announcement or consummation of the proposed transaction may negatively affect the market price of K-C and Kenvue capital stock or their operating results.
• Risk of product liability litigation or government/regulatory action, including product recalls or safety concerns.
• Risks related to inflation and other economic factors such as interest rate and currency exchange rate fluctuations.
• Government trade or similar regulatory actions, including tariffs and other trade constraints, impacting supply chains, commodity costs, and consumer spending.
• Natural disasters, acts of war, terrorism, catastrophes, pandemics, epidemics, or other disease outbreaks.
• Fluctuations in prices and availability of raw materials.
• Manufacturing difficulties, delays, or supply chain disruptions.
• Disruptions in capital and credit markets.
• Counterparty defaults, including customers, suppliers, and financial institutions.
• Impairment of goodwill and intangible assets.
• Changes in customer preferences.
• Severe weather conditions, regional instabilities, and hostilities.
• Potential competitive pressures on selling prices for K-C and Kenvue products.
• Energy costs.
• General economic and political conditions globally and in the markets where K-C and Kenvue operate, including consumer, customer, and supplier responses to sanctions.
• Challenges in maintaining key customer relationships.
• Competition, including technological advances, new products, and intellectual property attained by competitors.
• Challenges inherent in new product research and development.
• Uncertainty of commercial success for new and existing products and digital capabilities.
• Challenges to intellectual property protections, including counterfeiting.
• The ability of K-C and Kenvue to successfully execute business development strategy and other strategic plans.
• Changes to applicable laws and regulations and other requirements imposed by stakeholders.
• Changes in behavior and spending patterns of consumers.

Future Outlook

Forward-looking statements indicate expectations regarding the anticipated benefits and synergies of the proposed transaction, its impact on K-C's and Kenvue's business, future financial and operating results, prospects, cash flow generation, post-closing capital structure, growth initiatives, innovations, marketing, and net sales. However, these are subject to significant risks and uncertainties, and actual results could differ materially from current expectations.

Industry Context

This filing is a procedural communication related to a specific corporate transaction between two major players in the consumer goods and healthcare products sectors. It does not provide broader industry analysis or trends, focusing solely on the legal and regulatory aspects of the proposed merger.

Legal Proceedings

• The filing mentions the risk of litigation related to the proposed transaction, which could result in expense or delay.
• It also notes the risk of product liability litigation or government/regulatory action, including related to product liability claims, product efficacy, or safety concerns leading to recalls.

Stakeholder Impact

• The proposed transaction carries a risk of adversely affecting the ability of K-C and Kenvue to retain key personnel.
• There is a risk of negative impact on customer relationships and supplier agreements.
• The announcement or consummation of the transaction could have a negative effect on the market price of the capital stock of K-C and Kenvue, impacting shareholders.

Next Steps

• Stockholders of K-C and Kenvue need to approve their respective transaction-related proposals.
• K-C and Kenvue will continue to file necessary documents with the SEC regarding the proposed transaction.
• Investors and stockholders are encouraged to read all relevant SEC filings, including amendments and supplements.

Key Dates

Keywords

Kimberly-Clark, Kenvue, Merger, Acquisition, SEC Filing, Form 425, Proxy Solicitation, S-4 Registration, Stockholder Approval, Corporate Transaction, Consumer Goods, Healthcare Products